GNBT
APPROVED IN ECUADOR?
Generex's flagship product, Generex Oral-lyn?, is an oral insulin spray for the treatment of diabetes.
Generex Oral-lyn? is a liquid formulation of regular human insulin that is delivered to the buccal mucosa by way of the RapidMist? device,where absorption is limited to the mouth with no entry into the lungs. The rich vascularity of the buccal mucosa allows for much faster absorption of insulin and a shorter total duration of activity which makes Generex Oral-lyn? an ideal prandial insulin as it can be conveniently administered immediately prior to meals with little prospect of hypoglycemia. Generex Oral-lyn? can be used as a preventative pharmacologic agent by people with pre-diabetes to delay the onset of diabetes and by patients with type-2 diabetes to delay the onset of insulin dependence and the complications associated with diabetes.
Generex Oral-lyn? is expected to lead to an enormous improvement in the quality of life, with the elimination of pain and a significant increase in convenience. This will result in improved compliance with a relative decrease in complications and a significant reduction in the enormous costs associated with treating them.
